tradingkey.logo

Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings

ReutersSep 22, 2025 2:24 PM

- Strive ASST.O said on Monday it will acquire Semler Scientific SMLR.O in an all-stock deal valued at about $1.34 billion, as the bitcoin-treasury company backed by former Republican U.S. presidential candidate Vivek Ramaswamy moves to expand its cryptocurrency holdings.

Semler shareholders will receive 21.04 Class A common shares of Strive for each Semler share, valuing Semler at $90.52 per share, a premium of more than 210% to its Friday close.

The deal comes less than five months after Strive announced a merger with Asset Entities as part of its plan to list on Nasdaq and pursue a strategy of buying and holding bitcoin.

Shares of Semler rose 8.3% in early trading, while Strive fell 8%.

Strive also said it will purchase 5,816 bitcoin for a total of $675 million. The combined company would own more than 10,900 bitcoin and plans to fund future purchases using a “preferred equity only” model.

Semler, which in addition to bitcoin holdings operates a healthcare business, offers a point-of-care test that measures arterial blood flow in the extremities.

Ramaswamy, a longtime crypto advocate, co-founded Strive in 2022. He previously founded drugmaker Roivant Sciences ROIV.O in 2014 and left its board in February 2023 to focus on his presidential campaign.

The deal reflects growing corporate adoption of bitcoin treasury strategies, following the approach pioneered by Michael Saylor's Strategy MSTR.O, which began purchasing bitcoin with cash reserves in 2020.

Bitcoin BTC=BTSP has gained 20.5% this year, outpacing the S&P 500's .SPX 13.3% rise, as regulatory wins have helped bridge the gap between the cryptocurrency and traditional finance.

Cantor Fitzgerald acted as financial advisor to Strive on the deal, while LionTree Advisors served as advisor to Semler.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI